Nationalität
USA
Geburtsjahr
1973
1995
George Washington University, Washington, DC, BBA
2005–2007
Genentech, Senior Product Manager
2007–2010
Genentech, Group Product Manager / Associate Director GIO Pipeline Strategy & Operations
2010
Genentech, Divisional Sales Manager
2011–2012
Genentech, Marketing Director, Rituxan Immunologie
2012–2013
Genentech, Marketing Director, ACTEMRA
2013–2015
Genentech, Senior Director, Field Reimbursement Management
2015–2017
Roche Pharmaceuticals Basel. Lifecycle Leader. ACTEMRA
2017
Genentech, Vice President, Rheumatology / Nephrology
2018–2019
Genentech, Vice President, Avastin, Alecensa, Tarceva and Entrectinib, Lunge & GI Onkologie Sales
2019–2023
Roche Pharma Basel, Leiterin Globale Produktstrategie
Seit März 2023
Roche Pharma Basel, CEO, Mitglied der Konzernleitung
–
–
Seit 2022
Spark Therapeutics, Inc., Mitglied des Verwaltungsrats
Seit 2023
EFPIA, Mitglied des Verwaltungsrats
Seit 2023
Flatiron Health Inc., Mitglied des Verwaltungsrats
Seit 2003
Chugai Pharmaceutical Co., Ltd, Mitglied des Verwaltungsrats
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.